John Gill is President at PHARMATHENE, INC (PIP). They have made 5 open-market trades across 1 company since 2017, most recently 2026-04-06.
CIK 0001409939
3 open-market purchases totalling $138K since 2017, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PIP | 822,244 | $5.3M |
| ALT | 21,700 | $48K |
| Total | $5.4M |
Shares reported on the most recent Form 4, priced at the 2026-04-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ALT | BUY | 2026-04-06 | 2026-04-06 | $3.41 | $31K | +5.1% | -2.5% | -7.5% |
| ALT | BUY | 2025-12-23 | 2025-12-23 | $4.10 | $103K | -2.2% | +32.8% | -15.1% |
| ALT | SELL | 2022-08-12 | 2023-07-06 | $15.00 | $41K | -5.7% | -8.7% | -24.9% |
| ALT | SELL | 2020-11-30 | 2020-12-02 | $11.92 | $100K | +11.3% | +6.0% | +31.4% |
| ALT | BUY | 2017-06-02 | 2017-06-06 | $4.34 | $4K | -15.1% | -28.1% | -40.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.